Related Experiment Video
Updated: Jan 14, 2026

10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.5K
Degeneracy, as opposed to specificity, in immunotherapy
1Center for Neurologic Disease, Brigham and Women's Hospital and Harvard Medical School, Harvard Institutes of Medicine, Room 786, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA. dhafler@rics.bwh.harvard.edu
The Journal of Clinical Investigation
|March 6, 2002
Summary
No abstract available in PubMed .

